Releases | Medable

Releases

Medable and ICON Exceed Patient eConsent Adoption Goals for Women’s Health Study on Menopause

3 min

Medable and ICON exceeded eConsent adoption goals in a U.S. menopause study, with more than 85% of participants consenting electronically and 18 sites achieving 100% adoption.

New Data Reveals DCT Components Linked to Improvements in Clinical Trial Access Among Underrepresented Communities

4 min

Medable's groundbreaking study with the Tufts PACT Consortium highlights the transformative impact of decentralized clinical trials (DCTs) on diversity.

Medable Reports 80% Revenue Growth from Portfolio-Level eCOA Adoption, Sharp Increase Compared to Study-by-Study Adoption

4 min

Medable reports 80% revenue growth from portfolio-level eCOA adoption in 2024, reflecting growing confidence in scalable digital solutions for clinical trials.

New Medable AI Capabilities Simplify Digital Clinical Trial Launch with Instant eCOA Generation

3 min

Medable Studio is the first solution to leverage generative AI to reduce eCOA build times to seconds.

Medable Joins Forces with Google Cloud to Deliver Digital Clinical Trials Technology on Google Cloud Marketplace

3 min

Medable, a leading provider of clinical development technology, today announced a collaboration with Google Cloud to bring Medable’s Digital and Decentralized Clinical Trial Platform to Google Cloud Marketplace.

Medable Named Top Patient Engagement Trailblazer by Everest Group

4 min

Clinical research industry’s largest, most diverse global network of patient advocates improves the trial experience across therapeutic areas and technologies.

New Medable Studio Empowers Sponsors to Launch eCOA Solutions into Clinical Trials with Unparalleled Control and Efficiency

4 min

Medable Studio for eCOA now available; two top-10 pharma company early adopters.

Medable Wins 2024 Prix Galien UK Award for Best Digital Health Solution

3 min

Medable today announced that its evidence generation platform was awarded “Best Digital Health Solution” from a field of 17 nominees at the Prix Galien UK Forum in London. This marks the second time Medable has won the Best Digital Health Solution award, first taking home the honor in 2023 at the Prix Galien US ceremony.

New Research from Partnership for Advancing Clinical Trials (PACT) Reveals Decentralized Clinical Trials (DCTs) Beat Timeline Expectations

4 min

Medable today announced that the Partnership for Advancing Clinical Trials (PACT) consortium in conjunction with the Tufts Center for the Study of Drug Development (CSDD) has produced compelling results from a new study.

Medable and Masimo Partner to Bring Best-in-Class Wearable Devices to Clinical Research, Capturing Rich Subjective and Objective Data

4 min

Medable is partnering with industry leader Masimo to bring best-in-class medical-grade wearable devices to clinical research.

Medable Achieves 75% eConsent Adoption Across Elderly Patients in Pivotal U.S. Renal Care Clinical Trial

4 min

The Phase IV trial, funded by a top-10 global pharmaceutical company, had a narrow recruitment window to enroll patients suffering from Anemia in End Stage Kidney Disease (ESKD) across more than 40 dialysis centers, involving 476 site users.

Medable Partners with Duke BASE Lab to Study Patient Preference of Electronic Informed Consent in Clinical Trials

4 min

Medable announces results from a new research project with Duke University BASE Lab on enhanced electronic informed consent (eIC) in clinical trials.

Medable to Present at 42nd Annual J.P. Morgan Healthcare Conference

1 min

Medable CEO and Co-Founder Michelle Longmire will be presenting a corporate update at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco.